Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 70 results found. Search for [ COVID-19 vaccine J ]

Results 1 to 21 of 70
BusinessToday.In
October 21, 2020
AstraZeneca's large, late-stage U.S. trial has been on hold since Sept. 6, after a participant in the company's UK trial fell ill


BusinessToday.In
October 19, 2020
Presently, there are around 40 different coronavirus vaccines in various stages of human clinical trials, comprising one being developed by Oxford University and AstraZeneca, which is already in an advanced stage of testing


BusinessToday.In
October 16, 2020
Pfizer and BioNTech's vaccine candidate, BNT162b2, is currently being evaluated in a global Phase 3 study ongoing at more than 120 clinical sites worldwide including the United States, Brazil, South Africa and Argentina


PB Jayakumar
October 16, 2020
India may get COVID-19 vaccine by March 2021 provided the regulators signal with the processes fast as multiple manufacturers are working on it, and already two are in phase-3 trial and one in the phase-2 trial


Reuters
October 14, 2020
While severe COVID-19 symptoms are extremely rare in infected children, they can pass on the virus to high-risk groups such as the elderly


Reuters
October 14, 2020
Trump touted the Lilly drug, along with the antibody treatment from Regeneron Pharmaceuticals Inc that he received for his COVID-19, as tantamount to a cure in a video he posted last week


BusinessToday.In
October 14, 2020
Coronavirus vaccine update: Biopharma company Epygen Biotech with operations in Mumbai and Dubai is planning to launch an affordable COVID-19 vaccine with an aim to roll out 500 million doses within six months


BusinessToday.In
October 13, 2020
Johnson & Johnson sent out a document in which it stated the \"pausing rule\" has been met and the online system used to enrol patients in the study has been closed


BusinessToday.In
October 12, 2020
Coronavirus vaccine: There are four US-based companies whose vaccine candidates have moved into the crucial phase-3 development phase. This includes--Pfizer, Moderna, Johnson & Johnson, and Novavax


Joe C Mathew
October 9, 2020
At least 38 COVID-19 applications filed by Indian innovators are pending before Indian Patent Office since the outbreak of the pandemic in the country


BusinessToday.In
October 1, 2020
Coronavirus vaccine update: In India, there are three COVID-19 vaccines under human trials--Bharat Biotech's COVAXIN, Oxford's COVDSHIELD, and Zydus Cadila's ZyCoV-D. Serum Institute has already begun a phase-3 trial of Oxford vaccine candidates at 17 sites


BusinessToday.In
New Delhi, September 24, 2020
Delhi Deputy CM Manish Sisodia hospitalised due to COVID-19; 'Assess the impact of COVID lockdown on economic activities': PM Modi to CMs; TikTok to create 25,000 new jobs in the US amid ownership conflict. Watch this and more news on News Blast. BT Panorama: Apple's online store in India; What it offers to Indian consumers


Rashi Bisaria
New Delhi, September 24, 2020
COVID-19 vaccine: Johnson & Johnson begins global phase 3 trial with 60,000 peoplePharma giant Johnson & Johnson (J&J) has started a massive global phase 3 clinical trial with 60,000 people of its single-dose coronavirus vaccine. The volunteers will be recruited from the US, South Africa, Argentina, Brazil, Chile, Colombia, Mexico and Peru. \"Johnson & Johnson will develop and test its COVID-19 vaccine candidate in accordance with high ethical standards and sound scientific p...


BusinessToday.In
September 23, 2020
Pharma giant Johnson & Johnson (J&J) has started a massive global phase 3 clinical trial with 60,000 people of its single-dose coronavirus vaccine


BusinessToday.In
September 23, 2020
Phase 1 clinical trial of Codagenix' intranasal, live-attenuated vaccine candidate for SARS-CoV-2, is expected to initiate in the United Kingdom by the end of 2020


Reuters
September 18, 2020
In recent weeks, Pfizer has said it should know by the end of October whether the vaccine, developed together with Germany's BioNTech SE, is safe and effective


Reuters
September 5, 2020
J&J's vaccine is one of over a hundred worldwide being developed in response to the coronavirus pandemic, which has infected nearly 26.5 million people and led to some 869,323 deaths


BusinessToday.In
September 1, 2020
COVID-19 vaccine: The University of Oxford and AstraZeneca PLC has developed the first vaccine candidate to start the final round of testing of the coronavirus vaccine


Reuters
September 1, 2020
Many experts expressed skepticism about the Russian vaccine after the government declared its intention to give it to high-risk groups in October without data from large pivotal trials


PTI
August 25, 2020
Serum Institute of India has partnered with British-Swedish pharma company AstraZeneca for manufacturing the Covid-19 vaccine candidate, developed by the University of Oxford


PAGES 1 OF 4  1234